1. Kyaw, MH, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. New England Journal of Medicine 2006; 354: 1455–1463.
2. Freed, GL, Davis, MM, Clark, SJ. Variation in public and private supply of pneumococcal conjugate vaccine during a shortage. Journal of the American Medical Association 2003; 289: 575–578.
3. Flannery, B, et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. Journal of the American Medical Association 2004; 291: 2197–2203.
4. Anon. Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage – Advisory Committee on Immunization Practices. Journal of the American Medical Association 2002; 287: 833–834.
5. Butler, JC. Epidemiology of pneumococcal disease. In: Tuomanen, EIed. The Pneumococcus. Washington, DC: ASM Press, 2004, pp. 148–168.
6. HEDIS 2006 Health plan employer data & information set. Vol. 3: Specifications for survey measures. Washington, DC: National Committee for Quality Assurance (NCQA); 2005, p. 248.
7. The Ambulatory Care Quality Alliance Recommended Starter Set. Clinical Performance Measures for Ambulatory Care. Agency for Healthcare Research and Quality. Rockville, MD (http://www.ahrq.gov/qual/aqastart.htm). Accessed 30 September 2008.
8. Ahmed, F, et al. Cost-benefit analysis of a new HEDIS performance measure for penumococcal vaccination. Medical Decision Making 2002; 22: S58–66.
9. Robinson, KA, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998: opportunities for prevention in the conjugate vaccine era. Journal of the American Medical Association 2001; 285: 1729–1735.
10. Davis, MM. Race-based immunization recommendations and the potential to reduce health disparities. Journal of the American Medical Association 2004; 291: 2253–2255.
11. American Academy of Pediatrics, Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000; 106: 362–366.
12. Metlay, JP, et al. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine 2006; 24: 468–475.
13. Metlay, JP, et al. Macrolide resistance in adults with bacteremic pneumococcal pneumonia. Emerging Infectious Diseases 2006; 12: 1223–1230.
14. Czaja, C, Crossette, L, Metlay, JP. Accuracy of adult reported pneumococcal vaccination status of children. Annals of Epidemiology 2005; 15: 253–256.
16. Ruggles, S, et al. Integrated Public Use Microdata Series: Version 3.0 [Machine-readable database]. Minneapolis, MN: Minnesota Population Center; 2004 (http://www.ipums.org). Accessed 1 December 2005.
17. Southeastern Pennsylvania Household Health Survey. Philadelphia, PA: Philadelphia Health Management Corporation, 2004.
19. Kenward, MG, Carpenter, J. Multiple imputation: current perspectives. Statistical Methods in Medical Research 2007; 16: 199–218.
20. Allison, PD. Missing Data. Thousand Oaks, CA: Sage Publications, 2002.
21. Rothman, K. Modern Epidemiology, 2nd edn. Lippincott Williams & Wilkins, 1998.
22. Chen, FM, et al. Geocoding and linking data from population-based surveillance and the US Census to evaluate the impact of median household income on the epidemiology of invasive Streptococcus pneumoniae infections. American Journal of Epidemiology 1998; 148: 1212–1218.
23. Talbot, TR, et al. Asthma as a risk factor for invasive pneumococcal disease. New England Journal of Medicine 2005; 352: 2082–2090.
24. Thomsen, RW, et al. Risk of community-acquired pneumococcal bacteremia in patients with diabetes. Diabetes Care 2004; 27: 1143–1147.
25. Nuorti, JP, et al. Cigarette smoking and invasive pneumococcal disease. New England Journal of Medicine 2000; 342: 681–689.
26. ACIP. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommended Reports 1997; 46(RR-8): 1–24.
27. Shariatzadeh, MR, et al. Bacteremic pneumococcal pneumonia: a prospective study in Edmonton and neighboring municipalities. Medicine (Baltimore) 2005; 84: 147–161.